Activity of PD-1 blockade with nivolumab among patients with recurrent atypical/anaplastic meningioma: phase II trial results.
Saved in:
| Title: | Activity of PD-1 blockade with nivolumab among patients with recurrent atypical/anaplastic meningioma: phase II trial results. |
|---|---|
| Authors: | Bi WL; Department of Neurosurgery, Brigham and Women's Hospital, Boston, Massachusetts, USA., Nayak L; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Meredith DM; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, USA., Driver J; Department of Neurosurgery, Brigham and Women's Hospital, Boston, Massachusetts, USA., Du Z; Department of Molecular Diagnostics, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Guangzhou, China., Hoffman S; Department of Neurosurgery, Brigham and Women's Hospital, Boston, Massachusetts, USA., Li Y; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, Massachusetts, USA., Lee EQ; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Beroukhim R; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, Massachusetts, USA., Rinne M; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., McFaline-Figueroa R; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Chukwueke U; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., McCluskey C; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Gaffey S; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Cherniack AD; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Stefanik J; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Doherty L; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Taubert C; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Cifrino M; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., LaFrankie D; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Graillon T; Faculté de Médecine, Aix Marseille Université, Marseille, France., Wen PY; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Ligon KL; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, USA., Al-Mefty O; Department of Neurosurgery, Brigham and Women's Hospital, Boston, Massachusetts, USA., Huang RY; Department of Radiology, Brigham and Women's Hospital, Boston, Massachusetts, USA., Muzikansky A; Biostatistics Center, Massachusetts General Hospital, Boston, Massachusetts, USA., Chiocca EA; Department of Neurosurgery, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, Massachusetts, USA., Santagata S; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, USA., Dunn IF; Department of Neurosurgery, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA., Reardon DA; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA. |
| Source: | Neuro-oncology [Neuro Oncol] 2022 Jan 05; Vol. 24 (1), pp. 101-113. |
| Publication Type: | Clinical Trial, Phase II; Journal Article; Research Support, N.I.H., Extramural |
| Journal Info: | Publisher: Oxford University Press Country of Publication: England NLM ID: 100887420 Publication Model: Print Cited Medium: Internet ISSN: 1523-5866 (Electronic) Linking ISSN: 15228517 NLM ISO Abbreviation: Neuro Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1523-5866 |
|---|---|
| DOI: | 10.1093/neuonc/noab118 |
